EGM
BMRN icon

Engineers Gate Manager’s BioMarin Pharmaceuticals BMRN Stock Holding History

Engineers Gate Manager’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Sell
181,647
-255,213
-58% -$14M 0.13% 170
2026
Q1 		$24.7M Buy
436,860
+62,046
+17% +$3.62M 0.31% 60
2025
Q4 		$22.3M Buy
374,814
+251,905
+205% +$13.7M 0.26% 71
2025
Q3 		$6.66M Sell
122,909
-144,168
-54% -$8.24M 0.08% 317
2025
Q2 		$14.7M Buy
267,077
+180,357
+208% +$10.6M 0.18% 143
2025
Q1 		$6.13M Buy
86,720
+40,556
+88% +$2.73M 0.1% 268
2024
Q4 		$3.03M Sell
46,164
-64,533
-58% -$4.32M 0.05% 455
2024
Q3 		$7.78M Buy
110,697
+100,401
+975% +$8.39M 0.15% 168
2024
Q2 		$848K Buy
10,296
+5,258
+104% +$438K 0.02% 975
2024
Q1 		$440K Buy
+5,038
New +$451K 0.01% 1257
2023
Q3 		– Sell
-17,577
Closed -$1.52M – 1801
2023
Q2 		$1.52M Buy
17,577
+9,668
+122% +$910K 0.06% 469
2023
Q1 		$769K Sell
7,909
-9,971
-56% -$1.03M 0.03% 764
2022
Q4 		$1.85M Sell
17,880
-21,797
-55% -$2.05M 0.11% 211
2022
Q3 		$3.36M Buy
39,677
+26,262
+196% +$2.34M 0.21% 96
2022
Q2 		$1.11M Buy
+13,415
New +$1.07M 0.04% 631
2021
Q4 		– Sell
-3,541
Closed -$274K – 2022
2021
Q3 		$274K Buy
3,541
+941
+36% +$74.2K 0.02% 1244
2021
Q2 		$217K Sell
2,600
-13,275
-84% -$1.05M 0.01% 1360
2021
Q1 		$1.2M Buy
15,875
+7,852
+98% +$641K 0.06% 506
2020
Q4 		$704K Buy
+8,023
New +$636K 0.03% 763
2019
Q4 		– Sell
-38,705
Closed -$2.61M – 1619
2019
Q3 		$2.61M Buy
38,705
+9,305
+32% +$717K 0.13% 226
2019
Q2 		$2.52M Buy
+29,400
New +$2.52M 0.14% 232

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Engineers Gate Manager's BMRN Position: Q2 2026 in Review

Engineers Gate Manager reduced its BioMarin Pharmaceuticals (BMRN) stake by 58% in Q2 2026, selling an estimated $14M and leaving 181,647 shares worth $10.4M. The position accounts for 0.13% of the portfolio, ranked #170.

Engineers Gate Manager first reported a position in BMRN in Q2 2019 and has held it in 21 quarters since. The position peaked at $24.7M in Q1 2026. 561 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Engineers Gate Manager held 181,647 shares of BioMarin Pharmaceuticals worth $10.4M as of Q2 2026.
  • Engineers Gate Manager sold 255,213 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $14M.
  • BioMarin Pharmaceuticals made up 0.13% of Engineers Gate Manager's portfolio in Q2 2026, its #170 holding.
  • Engineers Gate Manager first reported a position in BioMarin Pharmaceuticals in Q2 2019 and has held it in 21 quarters since.
  • Engineers Gate Manager's BioMarin Pharmaceuticals position peaked at $24.7M in Q1 2026.
  • 561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.